Growing pharma sector to boost lab, diagnostics market
The Indian pharma industry has been growing at a compounded annual growth rate (CAGR) of more than 15% over the last five years and is expected to grow to $100 billion by 2025.
The Union Cabinet (Indian government) has given its goahead for the amendment of the existing Foreign Direct Investment (FDI) policy in the pharmaceutical sector in order to allow FDI up to 100 per cent under the automatic route for manufacturing of medical devices subject to certain conditions. The drugs and pharmaceuticals sector attracted cumulative FDI inflows worth $14.53 billion between April 2000 and December 2016, according to data released by the Department of Industrial Policy and Promotion (DIPP).
Analytica Anacon India and India Lab Expo, India’s leading trade fairs and conference for laboratory technology, analysis, biotechnology and diagnostics will capitalize on this growth opportunity by bringing industry stakeholders together at one place. Manufacturers, suppliers, dealers and representatives of Indian and international manufacturers will display the best of laboratory technology, analysis and biotechnology products, solutions and technologies.
Analytica Anacon India and India Lab Expo is co-organized on September 21 - 23, 2017, Hitex, Hyderabad with Indian Analytical Instruments Association (IAIA) and has received strong support from all major trade associations including Pharmexcil, Indian Drug Manufacturers' Association (IDMA), Indian Chemical Council (ICC) and many more.